Ritu Tomar

581 total citations
31 papers, 423 citations indexed

About

Ritu Tomar is a scholar working on Molecular Biology, Infectious Diseases and Nephrology. According to data from OpenAlex, Ritu Tomar has authored 31 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Nephrology. Recurrent topics in Ritu Tomar's work include Renal Diseases and Glomerulopathies (4 papers), Natural Antidiabetic Agents Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Ritu Tomar is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Natural Antidiabetic Agents Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Ritu Tomar collaborates with scholars based in India, United States and Saudi Arabia. Ritu Tomar's co-authors include Medicherla V. Jagannadham, Reetesh Kumar, Pinky Tripathi, Iain A. Drummond, Mandeep Kumar Arora, Jagannath Sahoo, Ashok Jangra, Santosh Kumar Rath, Barry I. Freedman and Caitlin C. O’Meara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Food Chemistry.

In The Last Decade

Ritu Tomar

28 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ritu Tomar India 12 199 92 83 62 43 31 423
Kyung-Yun Kang South Korea 14 152 0.8× 17 0.2× 92 1.1× 20 0.3× 36 0.8× 39 494
Jiahui Han China 14 213 1.1× 55 0.6× 58 0.7× 14 0.2× 12 0.3× 52 473
Xiangwei Xu China 9 245 1.2× 15 0.2× 36 0.4× 22 0.4× 18 0.4× 41 482
Sheau‐Chung Tang Taiwan 15 220 1.1× 29 0.3× 46 0.6× 13 0.2× 34 0.8× 24 581
Abheepsa Mishra United States 13 161 0.8× 12 0.1× 32 0.4× 63 1.0× 20 0.5× 17 394
Hend Ibrahim United States 12 256 1.3× 39 0.4× 32 0.4× 15 0.2× 40 0.9× 25 433
Hoyoung Lee South Korea 15 284 1.4× 8 0.1× 84 1.0× 51 0.8× 34 0.8× 34 682
Toshiyuki Higuchi Japan 12 90 0.5× 71 0.8× 149 1.8× 6 0.1× 30 0.7× 27 433
Jingwei Xiao China 11 224 1.1× 17 0.2× 48 0.6× 8 0.1× 22 0.5× 35 430
Su‐Bin Lee South Korea 12 118 0.6× 31 0.3× 45 0.5× 9 0.1× 51 1.2× 41 393

Countries citing papers authored by Ritu Tomar

Since Specialization
Citations

This map shows the geographic impact of Ritu Tomar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Tomar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Tomar more than expected).

Fields of papers citing papers by Ritu Tomar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritu Tomar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Tomar. The network helps show where Ritu Tomar may publish in the future.

Co-authorship network of co-authors of Ritu Tomar

This figure shows the co-authorship network connecting the top 25 collaborators of Ritu Tomar. A scholar is included among the top collaborators of Ritu Tomar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritu Tomar. Ritu Tomar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Sneh Lata, Vikas Sharma, & Ritu Tomar. (2025). Impact of AI-Driven Personalized Experience in Shaping Consumer Loyalty Towards Quick Commerce. 955–960.
3.
Tomar, Ritu, Sabya Sachi Das, Neha Kapoor, et al.. (2024). Allamanda cathartica (Linn.) leaf extract-encapsulated phytoemulsions: formulation, characterization and in vitroin vivo biological evaluations. Sustainable Food Technology. 2(5). 1490–1505. 3 indexed citations
5.
Tomar, Ritu, Sabya Sachi Das, Jagannath Sahoo, et al.. (2024). Therapeutic Implications of Dietary Polyphenols-Loaded Nanoemulsions in Cancer Therapy. ACS Applied Bio Materials. 7(4). 2036–2053. 14 indexed citations
6.
Sharma, Satish Kumar, Syed Mohammed Basheeruddin Asdaq, Mohammed Kanan Alshammari, et al.. (2022). Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: A narrative review. Journal of Infection and Public Health. 15(5). 566–572. 4 indexed citations
7.
Pathak, Anuj, et al.. (2022). Different aspects of polymers – A review article. Materials Today Proceedings. 64. 1490–1495. 7 indexed citations
8.
Imran, Mohd, et al.. (2022). Insight into the biological impact of COVID-19 and its vaccines on human health. Saudi Journal of Biological Sciences. 29(5). 3326–3337. 9 indexed citations
9.
Arora, Mandeep Kumar, Syed Mohammed Basheeruddin Asdaq, Ali A. Alshamrani, et al.. (2022). Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats. Molecules. 27(6). 1834–1834. 19 indexed citations
10.
Tomar, Ritu, et al.. (2022). Oxidative Stress: Meeting Multiple Targets in Pathogenesis of VascularEndothelial Dysfunction. Current Drug Targets. 23(9). 902–912. 3 indexed citations
11.
Pathak, Anuj, et al.. (2022). global prospective of medical devices and their regulations. International Journal of Health Sciences. 2764–2778. 2 indexed citations
12.
Arora, Mandeep Kumar, et al.. (2022). Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver disease. SHILAP Revista de lepidopterología. 8(1). 11 indexed citations
13.
Arora, Mandeep Kumar, Parul Grover, Syed Mohammed Basheeruddin Asdaq, et al.. (2021). Potential role of nicotinamide analogues against SARS-COV-2 target proteins. Saudi Journal of Biological Sciences. 28(12). 7567–7574. 4 indexed citations
14.
Chaudhary, Anurag, Ritu Tomar, Mohd Imran, et al.. (2021). In silico Screening of Phytochemicals as Potential Inhibitors of SARS-CoV-2 Mpro and Human ACE-2. International Journal of Pharmacology. 18(1). 104–115. 1 indexed citations
15.
Arora, Mandeep Kumar, et al.. (2021). Synergistic effect of Ocimum Sanctum and Andrographis Paniculata against Diabetic Complications. Journal of Pharmaceutical Research International. 151–163.
16.
Gupta, Rakesh, et al.. (2019). A study of hepatitis A virus seropositivity among children aged between 1 and 5 years of age: Implications for universal immunization. Medical Journal Armed Forces India. 75(3). 335–338. 4 indexed citations
17.
Olabisi, Opeyemi A., Khaldoun Al‐Romaih, Joel Henderson, et al.. (2016). From man to fish: What can Zebrafish tell us about ApoL1 nephropathy?. Clinical Nephrology. 86(S1). 114–118. 22 indexed citations
18.
Yeo, Nan Cher, Caitlin C. O’Meara, Ritu Tomar, et al.. (2014). Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity. Genome Research. 25(1). 57–65. 47 indexed citations
19.
Tomar, Ritu, Sudha Mudumana, Narendra Pathak, Neil A. Hukriede, & Iain A. Drummond. (2014). osr1 Is Required for Podocyte Development Downstream of wt1a. Journal of the American Society of Nephrology. 25(11). 2539–2545. 18 indexed citations
20.
Kumar, Reetesh, et al.. (2011). Biochemical and spectroscopic characterization of a novel metalloprotease, cotinifolin from an antiviral plant shrub: Euphorbia cotinifolia. Plant Physiology and Biochemistry. 49(7). 721–728. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026